Got $10,000? 3 Top Stocks to Buy to End the Year Right
In a year where societal habits and the traditional workplace have been completely upended, there appears to be light at the end of the tunnel.
In November, two coronavirus disease 2019 (COVID-19) vaccine developers announced stellar results from interim analyses of their large phase 3 studies. While researchers were expecting a vaccine efficacy (VE) of between 50% and 60%, Pfizer/BioNTech and Moderna produced respective VEs of 95% and 94.5% in their interim data. With an end to the pandemic now in sight, the benchmark S&P 500 might end 2020 higher by a double-digit percentage. That's hard to believe, considering the S&P 500 lost 34% in a matter of weeks during the first quarter.
The end of the pandemic wouldn't just be a win for humanity -- it would be a big win for the investing community. A number of high-growth trends have flourished in recent quarters, and that could continue at an even more accelerated pace once the U.S. and global economy are fully reopened.
Source Fool.com
